ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $100,996,000 | -29.8% | 2,498,826 | -0.1% | 0.01% | -20.0% |
| Q2 2015 | $143,929,000 | -28.7% | 2,500,831 | -21.1% | 0.02% | -28.6% |
| Q1 2015 | $201,885,000 | +26.7% | 3,170,831 | +22.9% | 0.02% | +31.2% |
| Q4 2014 | $159,317,000 | +53.3% | 2,580,447 | -3.6% | 0.02% | +45.5% |
| Q3 2014 | $103,933,000 | +25.3% | 2,676,552 | +11.2% | 0.01% | +22.2% |
| Q2 2014 | $82,941,000 | -20.3% | 2,407,618 | -0.0% | 0.01% | -25.0% |
| Q1 2014 | $104,042,000 | -21.1% | 2,407,833 | -59.1% | 0.01% | +50.0% |
| Q4 2013 | $131,922,000 | +32.8% | 5,886,568 | +122.4% | 0.01% | -33.3% |
| Q3 2013 | $99,345,000 | +36.4% | 2,646,261 | -2.4% | 0.01% | +33.3% |
| Q2 2013 | $72,830,000 | – | 2,710,419 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
| WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
| DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
| HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
| Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
| PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
| Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
| Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
| PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |